研究工作

首页 » 研究工作 » 科研团队 当前位置:

Dong Joon Kim教授

 

Dong Joon Kim,男,1976年生,国籍韩国。1999年毕业于韩国忠南大学,2007年获忠南大学药理学博士学位。2001年起,先后任韩国生物技术培训研究员、博士后研究员、荷美尔研究院博士后研究员。2016年至今,任中美(河南)荷美尔肿瘤研究院PI。

所获奖项:

 2012.5 – 2014.5  基础技术研究组 Research Fellowship for Young Scientists    

 2008.7 –2012.5   Post-doctoral Research fellowship,  美国明尼苏大学, Hormel研究所

 2007 – 2008.6    Post-doctoral Research fellowship,  医学介质研究中心 韩国生物技术研究员  

 2001.3–2001.9    Graduate Academic Excellent Scholarship Award,  韩国忠南大学, 农业生命科学学院 

1995.9-1998.3    Undergraduate Academic Excellent Scholarship Award,韩国忠南大学, 农业生命科学学院  

发表论文(部分):

1. Kim DJ, Lee MH, Shim JH, Carper A, Bode AM and Dong Z.2015. Herbacetin suppresses skin tumor growth through targeting ODC.(Prepare manuscript).  

2. Kim DJ, Lee MH, Oi N, Kim MO, Bode AM and Dong Z.2015. Direct targeting of COX2 by DIM prevents colon cancer.(Prepare manuscript).

3. Kim DJ, Roh E, Lee MH, Oi N, Lim DY, Kim MO, Cho YY, Pugliese A, Shim JH, Chen H, Cho EJ, Kim JE, Kang SC, Paul S, Kang HE, Jung JW, Lee SY, Kim SH, Reddy K, Yeom YI, Bode AM and Dong Z.2015. Herbacetin is a novel allosteric inhibitor of ornithine decarboxylase with antitumor activity.Cancer Research.(Accepted) IF-9.329 SCI, ISSN: 00085472, Publisher: American Association for Cancer Research

4. Kim DJ, Park YS, Kang MG, You Y, Jung Y, Koo H, Kim J, Kim M, Hong S, Park KC and Yeom YI.,2015. Pyruvate kinase isoenzyme M2 is a therapeutic target of gemcitabine chemoresistance in pancreatic cancer cells.Experimental Cell Research.

1;336(1):119-29. IF-3.246 2015-08-01 SCI, ISSN: 00144827, Publisher: Elseviera

5. Kim DJ, Park YS, Kim ND, Min SH, You Y, Jung Y, Koo H, Noh H, Kim J, Park KC and Yeom YI.2015. A Novel Pyruvate Kinase M2 Activator Compound that Suppresses Lung Cancer Cell Viability under Hypoxia.Molecules and Cells. 30;38(4):373-9 IF-2.09 2015-04-01 SCI, ISSN: 10168478 Publisher: Korean Society for Molecular and Cellular Biology

6. Lee MH*, Huang Z*,Kim DJ*, Kim SH*, Kim MO, Lee SY, Xie H, Par SJ, Kim JY, Kundu JK, Bode AB, Surth YJ and Dong Z.2013. Direct targeting of MEK1/2 and RSK2 by silybin induces cell-cycle arrest and inhibits melanoma cell growth.Cancer Prevention Research (Phila). 6(5):455-65. IF-4.444 2013-05-01 SCIE, ISSN: 19406207, Publisher: American Association for Cancer Research

7. Kim DJ*, Lee MH*, Reddy S, Li Y, Lim DY, Xie H, Lee SY, Yeom YI, Bode AM and Dong Z.2013. CInQ-03, a novel allosteric MEK inhibitor, suppresses cancer growth in vitro and in vivo.Carcinogenesis 34(5):1134-43 IF-5.334 2013-05-01 SCI, ISSN: 01433334, Publisher: Oxford University Press

8. Kim DJ, Li Y, Reddy K, Lee MH, Kim MO, Cho YY, Lee SY, Kim JE, Bode AM and Dong Z.2012. Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth.Cancer Research. 15;72(12):3060-8. IF-9.329 2012-06-01 SCI, ISSN: 00085472, Publisher: American Association for Cancer Research

9. Kim DJ, Reddy K, Kim MO, Li Y, Nadas J, Cho YY, Kim JE, Shim J, Song NR, Carper A, Lubert RA, Bode AM, Dong Z.2011. (3-Chloroacetyl)-indole, a novel allosteric AKT inhibitor, suppresses colon cancer growth in vitro and in vivo.Cancer Prevention Research (Phila). 4(11):1842-51. IF-4.444 2011-11-01 SCIE, ISSN: 19406207, Publisher: American Association for Cancer Research

10. Urusova D*, Shim J*,Kim DJ*, Jung SK*, Zykova T, Carper A, Bode AM, Dong Z.2011. Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1.Cancer Prevtion Research (Phila). 4(9):1366-77. IF-4.444 2011-09-01 SCIE, ISSN: 19406207, Publisher: American Association for Cancer Research

 

Copyright ©  中美(河南)荷美尔肿瘤研究院所有

地址:郑州市金水区东明路127号   电话:0371-65587276    邮编:450003   邮箱:hormelchina@126.com

豫ICP备15021085号-1 技术支持:维创盈通